These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 38203290)

  • 41. miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221.
    Kotani A; Ha D; Hsieh J; Rao PK; Schotte D; den Boer ML; Armstrong SA; Lodish HF
    Blood; 2009 Nov; 114(19):4169-78. PubMed ID: 19749093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia.
    Schotte D; Akbari Moqadam F; Lange-Turenhout EA; Chen C; van Ijcken WF; Pieters R; den Boer ML
    Leukemia; 2011 Sep; 25(9):1389-99. PubMed ID: 21606961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia.
    Zanette DL; Rivadavia F; Molfetta GA; Barbuzano FG; Proto-Siqueira R; Silva WA; Falcão RP; Zago MA
    Braz J Med Biol Res; 2007 Nov; 40(11):1435-40. PubMed ID: 17934639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia.
    Organista-Nava J; Gómez-Gómez Y; Illades-Aguiar B; Del Carmen Alarcón-Romero L; Saavedra-Herrera MV; Rivera-Ramírez AB; Garzón-Barrientos VH; Leyva-Vázquez MA
    Oncol Rep; 2015 Apr; 33(4):1639-49. PubMed ID: 25672522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia.
    Akbari Moqadam F; Lange-Turenhout EA; Ariës IM; Pieters R; den Boer ML
    Leuk Res; 2013 Oct; 37(10):1315-21. PubMed ID: 23915977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia.
    Mosakhani N; Missiry ME; Vakkila E; Knuutila S; Vakkila J
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):585-588. PubMed ID: 29068867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
    Schotte D; Lange-Turenhout EA; Stumpel DJ; Stam RW; Buijs-Gladdines JG; Meijerink JP; Pieters R; Den Boer ML
    Haematologica; 2010 Oct; 95(10):1675-82. PubMed ID: 20494936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment.
    Gutierrez-Camino Á; Umerez M; Lopez-Lopez E; Santos-Zorrozua B; Martin-Guerrero I; de Andoin NG; Ana S; Navajas A; Astigarraga I; Garcia-Orad A
    Pharmacogenomics; 2018 Dec; 19(18):1403-1412. PubMed ID: 30479191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacoepigenetics in childhood acute lymphoblastic leukemia: involvement of miRNA polymorphisms in hepatotoxicity.
    Gutierrez-Camino A; Umerez M; Santos B; Martin-Guerrero I; García de Andoin N; Sastre A; Navajas A; Astigarraga I; Garcia-Orad A
    Epigenomics; 2018 Apr; 10(4):409-417. PubMed ID: 29569486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
    Agirre X; Vilas-Zornoza A; Jiménez-Velasco A; Martin-Subero JI; Cordeu L; Gárate L; San José-Eneriz E; Abizanda G; Rodríguez-Otero P; Fortes P; Rifón J; Bandrés E; Calasanz MJ; Martín V; Heiniger A; Torres A; Siebert R; Román-Gomez J; Prósper F
    Cancer Res; 2009 May; 69(10):4443-53. PubMed ID: 19435910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.
    Beesley AH; Cummings AJ; Freitas JR; Hoffmann K; Firth MJ; Ford J; de Klerk NH; Kees UR
    Br J Haematol; 2005 Nov; 131(4):447-56. PubMed ID: 16281934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relapse of acute lymphoblastic leukemia in children in the context of microarray analyses.
    Szczepanek J; Styczyński J; Haus O; Tretyn A; Wysocki M
    Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):61-8. PubMed ID: 21246408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers.
    Staal FJ; van der Burg M; Wessels LF; Barendregt BH; Baert MR; van den Burg CM; van Huffel C; Langerak AW; van der Velden VH; Reinders MJ; van Dongen JJ
    Leukemia; 2003 Jul; 17(7):1324-32. PubMed ID: 12835720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of miR-708 and its targets in the childhood common precursor B-cell ALL.
    Li X; Li D; Zhuang Y; Shi Q; Wei W; Ju X
    Pediatr Blood Cancer; 2013 Dec; 60(12):2060-7. PubMed ID: 23970374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular Characterization of the Response to Conventional Chemotherapeutics in Pro-B-ALL Cell Lines in Terms of Tumor Relapse.
    Gladbach YS; Sklarz LM; Roolf C; Beck J; Schütz E; Fuellen G; Junghanss C; Murua Escobar H; Hamed M
    Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia.
    Feng DD; Zhang H; Zhang P; Zheng YS; Zhang XJ; Han BW; Luo XQ; Xu L; Zhou H; Qu LH; Chen YQ
    J Cell Mol Med; 2011 Oct; 15(10):2164-75. PubMed ID: 21070600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging roles of microRNAs in acute lymphoblastic leukemia and their clinical prospects.
    Deng W; Pan M; Zhu S; Chao R; Wang L
    Expert Rev Hematol; 2021 Nov; 14(11):987-992. PubMed ID: 34784832
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse.
    Shalapour S; Hof J; Kirschner-Schwabe R; Bastian L; Eckert C; Prada J; Henze G; von Stackelberg A; Seeger K
    Haematologica; 2011 Nov; 96(11):1627-35. PubMed ID: 21828124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PI3K/AKT pathway-related microRNA variants in childhood acute lymphoblastic leukemia.
    Xue Y; Sun X; Fu J; Rong L; Zhang H; Zhu Y; Yang X; Hu S; Chen J; Fang Y
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30545. PubMed ID: 37438860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prognostic Significance of Joint Detection of miR-210 and Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia].
    Mei YY; Li ZG; Zhang Y; Zhang WL; Zhang PW; Wang N; Huang DS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):66-71. PubMed ID: 28245377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.